Shuttle Pharmaceuticals Holdings Inc.
Organization details
- Legal name
- Shuttle Pharmaceuticals Holdings Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Gaithersburg
- Headquarters state / province
- Maryland
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- SHPH
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001757499
Board of directors
-
Adam Chambers V · DirectorSince 2025
-
Anatoly Dritschilo · Director · CEO and ChairmanSince 2023
-
Angel Liriano · DirectorSince 2025
-
Arachchige Sachin Eranga Pathigoda · DirectorSince 2025
-
Bette Jacobs · DirectorSince 2023
-
Chris Senanayake · DirectorSince 2024
-
George Scorsis · DirectorSince 2025
-
Joseph Tung · DirectorSince 2025
-
Joshua Schafer · DirectorSince 2025
-
Milton Brown · DirectorSince 2023
-
Oleh Nabyt · DirectorSince 2025
-
Steven M. Richards · DirectorSince 2023
Chief executives
Director election results
Annual meeting of May 21, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
93.7%
-
95.4%
-
95.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $181,764
- 6 purchases by 1 insider
- Sold, last 12 months
- $504,832
- 5 sales by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 14, 2026 | HRT FINANCIAL LP 10% owner | Open-market sale | −82,116 | $4.48 | $367,880 |
| Jul 13, 2026 | HRT FINANCIAL LP 10% owner | Open-market sale | −1,033 | $4.67 | $4,824 |
| Jul 10, 2026 | HRT FINANCIAL LP 10% owner | Open-market purchase | +731 | $3.11 | $2,273 |
| Jul 9, 2026 | HRT FINANCIAL LP 10% owner | Open-market purchase | +8,266 | $3.38 | $27,939 |
| Jul 8, 2026 | HRT FINANCIAL LP 10% owner | Open-market sale | −18,531 | $3.52 | $65,229 |
| Jul 7, 2026 | HRT FINANCIAL LP 10% owner | Open-market sale | −10,580 | $3.33 | $35,231 |
| Jul 6, 2026 | HRT FINANCIAL LP 10% owner | Open-market sale | −9,022 | $3.51 | $31,667 |
| Jul 2, 2026 | HRT FINANCIAL LP 10% owner | Open-market purchase | +7,851 | $3.54 | $27,793 |
| Jul 1, 2026 | HRT FINANCIAL LP 10% owner | Open-market purchase | +3,959 | $3.30 | $13,065 |
| Jun 30, 2026 | HRT FINANCIAL LP 10% owner | Open-market purchase | +6,755 | $3.23 | $21,819 |
| Jun 29, 2026 | HRT FINANCIAL LP 10% owner | Open-market purchase | +25,836 | $3.44 | $88,876 |
| Dec 31, 2024 | Joshua Schafer Director | Grant or award | +209,790 | — | — |
| Dec 31, 2024 | Steven M. Richards Director | Grant or award | +209,790 | — | — |
| Dec 23, 2024 | Milton Brown Director | Grant or award | +209,790 | — | — |
| May 1, 2024 | Jung Mira Officer (Chief Scientific Officer) | Grant or award | −598 | $11.28 | $6,745 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Shuttle Pharmaceuticals Holdings Inc.
Who is the CEO of Shuttle Pharmaceuticals Holdings Inc.?
Anatoly Dritschilo is Shuttle Pharmaceuticals Holdings Inc.'s CEO and Chairman.
How many directors are on Shuttle Pharmaceuticals Holdings Inc.'s board?
Shuttle Pharmaceuticals Holdings Inc.'s board has 12 directors: Adam Chambers V, Anatoly Dritschilo, Angel Liriano, Arachchige Sachin Eranga Pathigoda, Bette Jacobs, Chris Senanayake, George Scorsis, Joseph Tung, Joshua Schafer, Milton Brown and 2 others.
Are Shuttle Pharmaceuticals Holdings Inc. insiders buying or selling shares?
Over the last 12 months, Shuttle Pharmaceuticals Holdings Inc. insiders bought $181,764 of shares in 6 purchases and sold $504,832 of shares in 5 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="shuttle-pharmaceuticals-holdings-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.